Katrina Taylor’s breast implants made her sick. This new device could make women feel whole again. On Monday, Australian surgeons began using 3D-printed breast scaffolds in a groundbreaking clinical trial aimed at offering an alternative to traditional silicone implants for women suffering from complications such as ruptures, infections, and a range of symptoms associated with breast implant illness. The trial, led by Professor Anand Deva, head of Plastic and Reconstructive Surgery at Macquarie University, involves forty-two Australian women who have had their silicone implants replaced with absorbable scaffolds designed to dissolve over time, allowing the body to regenerate its own fat tissue. The initiative traces back to an email received by Deva around fifteen years ago from a PhD student named Mohit Chayya, who proposed using an absorbable breast scaffold to promote tissue regeneration. At the time, Deva dismissed the idea, telling him to call in ten years when he might be ready for human trials. Now, nearly two decades later, the concept has evolved into a reality through the work of BellaSeno, a medtech company co-founded by Chayya, who serves as its CEO. The trial marks a pivotal moment in the field of reconstructive surgery, aiming to provide a safer and more organic alternative for women seeking breast reconstruction following mastectomies or lumpectomies due to breast cancer. The 3D-printed scaffolds are constructed from a polymer known as polycaprolactone, a material widely used in absorbable sutures. Each scaffold features a crisscross pattern of bands and fine filaments, making it approximately 90 percent porous. The smallest size weighs just 10 grams, significantly lighter than conventional implants. During the procedure, surgeons extract fat from the patient's abdomen, buttocks, or thighs via liposuction and inject it into the scaffold, filling up to 50 percent of its volume. Over the course of two to three years, the body gradually absorbs the scaffold, leaving behind the patient’s own regenerated fat tissue. Professor Deva described the regenerative process as “incredible,” emphasizing how it unlocks the body’s innate ability to heal and generate its own tissue without leaving any residual foreign material. Trial participants, including Katrina Taylor, have already begun experiencing the benefits of the technology. Taylor, who underwent the procedure five months prior, noted that the scaffolds felt natural and firm, though still slightly perceptible due to the ongoing absorption process. She expressed relief at finally feeling whole again after enduring years of discomfort caused by ruptured implants. For many women, the decision to undergo breast implant surgery comes with both physical and psychological risks. Complications such as implant rupture, infection, and chronic inflammation have prompted growing concerns among patients and medical professionals alike. These issues have fueled interest in alternatives that minimize long-term health risks while maintaining aesthetic outcomes. The 3D-printed scaffolds aim to address these concerns by providing a biocompatible structure that supports the body’s natural healing processes rather than relying on synthetic materials. Mohit Chayya, whose personal motivation stems from witnessing his grandmother’s struggles with a deformity resulting from a lumpectomy in Gujarat, India, emphasized the importance of offering viable solutions to those who lack access to advanced reconstructive care. His grandmother’s experience inspired him to pursue research that could one day benefit others facing similar challenges. While the current trial focuses on patients who have previously undergone silicone implant procedures, the ultimate goal is to expand the application of the technology to individuals requiring post-cancer reconstruction. As the trial progresses, researchers will continue monitoring the long-term effects of the scaffolds, ensuring their safety and effectiveness before seeking regulatory approval. If successful, the technology could represent a major advancement in reconstructive surgery, offering a more sustainable and biologically integrated approach to breast reconstruction. For now, the focus remains on gathering data and refining the technique, with the hope that future generations of patients will benefit from a treatment that aligns with the body’s natural regenerative capabilities.
★
Keep the news honest.
ObjectiveNews is reader-funded and ad-free — we show you the bias instead of hiding it. Support independent journalism for €4/month.
Become a Supporter
Australia
